Connect with us

Health

Cardioprotective therapies fail to prevent LVEF decline in early breast cancer treatment – Healio

Neurohormonal blockade using candesartan and/or metoprolol for women undergoing treatment for early breast cancer was not significantly protective against minor…

Published

on

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected] to Healio
Neurohormonal blockade using candesartan and/or metoprolol for women undergoing treatment for early breast cancer was not significantly protective against minor long-term decline in left ventricular ejection fraction, a speaker reported.
According to data presented at the virtual American College of Cardiology Scientific Session, concomitant…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Melbourne townhouse forced to isolate – Forbes Advocate
Article feature image
Melbourne townhouse forced to isolate – Bunbury Mail